Microcap & Penny Stocks | The Microcap Kitchen: Stocks 5¢ to $5


Previous 10 | Next 10 
From: Catfish5/8/2012 9:20:37 AM
   of 111110
 
NEWT - $1.36 This is now up to $1.46 in pre-market on this news.

Newtek Business Services, Inc. Reports First Quarter 2012 Net Income Of $1.3 Million; EPS Of $0.04 Per Diluted Share --2012 Guidance Increased to $7.5 Million Pretax Income Midpoint and $15.3 Million Modified EBITDA Midpoint --Announces 2012 EPS Midpoint Guidance of $0.12 per Diluted Share







NEW YORK, May 8, 2012 /PRNewswire via COMTEX/ -- Newtek Business Services, Inc. /quotes/zigman/84238/quotes/nls/newt NEWT -3.55% ( www.thesba.com ) The Small Business Authority, a provider of business services and financial products to the small- and medium-sized business market, reported today its financial results for the quarter ended March 31, 2012.

First Quarter 2012 Highlights:

The Company had consolidated pretax income of $2.1 million; an increase of $1.3 million compared to the first quarter of 2011.

The Company had consolidated net income attributable to Newtek Business Services (excludes non-controlling interests) of $1.3 million; an increase of $794 thousand compared to the first quarter of 2011, and EPS of $0.04 per diluted share as compared to $0.01 per diluted share for the first quarter of 2011.

Consolidated Modified EBITDA was $3.6 million, as compared to $2.6 million for the first quarter of 2011.

Electronic payment processing segment pretax income increased 72% to $2.1 million in the first quarter of 2012 as compared to $1.2 million in the first quarter of 2011.

Small business finance segment pretax income increased 15% to $1.5 million in the first quarter of 2012 as compared to $1.3 million in the first quarter of 2011.

Our SBA lender funded $25 million of loans in the first quarter of 2012 as compared to $19 million during the same period in 2011.

The Company signed an agreement with Summit Partners for $10 million - $15 million in mezzanine debt on April 26, 2012 to be used to support Newtek's continued growth and provide working capital necessary to expand its product offerings.

The Company expects full year EPS of between $0.10 and $0.13 per diluted share for 2012.

The Company is revising its guidance for pretax income to between $6.5 million and $8.5 million, up from its previously issued guidance of $5.0 million to $7.0 million, and Modified EBITDA to between $14.3 million and $16.3 million, up from its previously issued guidance of $11.0 million to $13.0 million.

Barry Sloane, Chairman, President and Chief Executive Officer said "We are elated at the financial results of the business and its model as years of planning and investment are paying off in growing earnings for our shareholders. Our electronic payment processing and small business finance segments are driving results while our managed technology solutions segment repositions and refocuses its efforts on new products and creating efficiencies for our clients.

"Our Modified EBITDA midpoint forecast of $15.3 million and pretax income midpoint forecast of $7.5 million is indicative of our strategy succeeding. Our recent mezzanine capital raise allows us to grow our lending business. Every $100 million of SBA 7(a) loan originations equates to an estimated additional $4 million of pretax income. We believe our future is bright and we anticipate growth in earnings and revenue for the remainder of 2012."

First Quarter 2012 Financial Results

For the quarter ended March 31, 2012, the Company had consolidated pretax income of $2.1 million, compared to $834 thousand in 2011, an increase of $1.3 million. The Company reported first quarter 2012 consolidated net income attributable to Newtek Business Services, Inc. of $1.3 million or $0.04 per share for the quarter, as compared to $509 thousand, or $0.01 per share in the first quarter of 2011. Improvements in both the pretax and after tax earnings are attributable in part to improvements in pretax income of all segments except Managed technology solutions.

For the quarter ended March 31, 2012, total consolidated operating revenues increased $206 thousand to $30.7 million compared to $30.5 million for the first quarter of 2011. Total net change in fair value increased by $1 million to a loss of $58 thousand for the quarter ended March 31, 2012, from a loss of $1.1 million for the quarter ended March 31, 2011. The decrease in fair value loss for the period was attributable to a reduction in the discount the Company uses to measure the fair value of loans held for investment, as well as a fair value loss recognized in the first quarter of 2011 for SBA loans transferred, subject to premium recourse.

Revised Outlook for 2012

The Company now expects 2012 consolidated revenues of between $129.1 million and $132.2 million and pretax income of between $6.5 million and $8.5 million. Midpoint Modified EBITDA is forecast at $15.3 million. Annual guidance by segment for revenue, pretax income (loss) and Modified EBITDA will be provided in the conference call presentation today Tuesday, May 8, 2012 at 4:15 p.m. ET and will be available in the 'Events & Presentations' section of the Investor Relations portion of Newtek's website at www.thesba.com .

Cautionary Statement

2012 Guidance information contained in this press release is based on management's current expectations. These statements are forward-looking and actual results may differ materially. See "Note Regarding Forward-Looking Statements" below.

Use of Non-GAAP Financial Measures

In evaluating its business, Newtek considers and uses Modified EBITDA as a supplemental measure of its operating performance. The Company defines Modified EBITDA as earnings before income from tax credits, interest expense, taxes, depreciation and amortization, stock compensation expense, other than temporary decline in value of investments, Capco fair value change and the loss on the lease restructure. The Company also presents Modified EBITDA because it believes it is frequently used by securities analysts, investors and other interested parties as a measure of financial performance.

The term Modified EBITDA is not defined under U.S. generally accepted accounting principles, or U.S. GAAP, and is not a measure of operating income (loss), operating performance or liquidity presented in accordance with U.S. GAAP. Modified EBITDA has limitations as an analytical tool and, when assessing the Company's operating performance, investors should not consider Modified EBITDA in isolation, or as a substitute for net income (loss) or other consolidated income statement data prepared in accordance with U.S. GAAP. Among other things, Modified EBITDA does not reflect the Company's actual cash expenditures. Other companies may calculate similar measures differently than Newtek, limiting their usefulness as comparative tools. The Company compensates for these limitations by relying primarily on its GAAP results supplemented by Modified EBITDA.

First Quarter 2012 Conference Call and Webcast

A conference call to discuss these results will be hosted by Barry Sloane, Chairman, President and Chief Executive Officer, and Jennifer Eddelson, Chief Accounting Officer, today, Tuesday, May 8, 2012 at 4:15 p.m. ET. The live conference call can be accessed by dialing (877) 303-6993 or (760) 666-3611.

A live audio webcast of the call and the corresponding presentation will be available in the 'Events & Presentation' section of the Investor Relations portion of Newtek's website at investor.newtekbusinessservices.com  . A replay of the webcast with the corresponding presentation will be available on Newtek's website shortly following the live presentation. The telephone replay can be accessed by dialing (855) 859-2056 or (404) 537-3406 and entering code 73471638. Both web-based and telephonic replays will be available through May 14, 2012.

About Newtek Business Services, Inc.

Newtek Business Services, Inc., The Small Business Authority, is a direct distributor of a wide range of business services and financial products to the small- and medium-sized business market under the Newtek® brand. Since 1999, Newtek has helped small- and medium-sized business owners realize their potential by providing them with the essential tools needed to manage and grow their businesses and to compete effectively in today's marketplace. Newtek provides one or more of its services to over 100,000 business accounts and has positioned the Newtek® and The Small Business Authority brands as a one-stop-shop provider of such business services. According to the U.S. Small Business Administration, there are over 27.5 million small businesses in the United States, which in total represent 99.7% of all employer firms.

Newtek Business Services, The Small Business Authority, provides the following products and services:

Electronic Payment Processing: eCommerce, electronic solutions to accept non-cash payments, including credit and debit cards, check conversion, remote deposit capture, ACH processing, and electronic gift and loyalty card programs.

Web Hosting: Full-service web host which offers eCommerce solutions, shared and dedicated web hosting and related services including domain registration and online shopping cart tools.

eCommerce: A suite of services that enable small businesses to get up and running on-line quickly and cost effectively, with integrated web design, payment processing and shopping cart services.

Business Lending: Broad array of lending products including SBA 7(a) and SBA 504 loans.

Insurance Services: Commercial and personal lines of insurance, including health and employee benefits in all 50 states, working with over 40 insurance carriers.

Web Services: Customized web design and development services.

Data Backup, Storage and Retrieval: Fast, secure, off-site data backup, storage and retrieval designed to meet the specific regulatory and compliance needs of any business.

Accounts Receivable Financing: Receivable purchasing and financing services.

Payroll: Complete payroll management and processing services.

Note Regarding Forward-Looking Statements

Statements in this press release including statements regarding Newtek's beliefs, expectations, intentions or strategies for the future, may be "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. All forward-looking statements involve a number of risks and uncertainties that could cause actual results to differ materially from the plans, intentions and expectations reflected in or suggested by the forward-looking statements. Such risks and uncertainties include, among others, intensified competition, operating problems and their impact on revenues and profit margins, anticipated future business strategies and financial performance, anticipated future number of customers, business prospects, legislative developments and similar matters. Risk factors, cautionary statements and other conditions which could cause Newtek's actual results to differ from management's current expectations are contained in Newtek's filings with the Securities and Exchange Commission and available through sec.gov  .

For more information, please visit www.thesba.com .

Contact: Newtek Business Services, Inc. Barry Sloane Chairman and CEO 212-356-9500 bsloane@thesba.com

Rubenstein Public Relations Telephone: (212) 843-9335 Contact: Jonathan Goldberg / jgoldberg@rubensteinpr.com

Rubenstein Investor Relations Telephone: (212) 843-9337 Contacts: Timothy Clemensen / tclemensen@rubensteinir.com William Swalm / bswalm@rubensteinir.com

Share Recommend | Keep | Reply | Mark as Last Read

From: m2pr5/8/2012 11:06:13 AM
   of 111110
 
AEMD - News
finance.yahoo.com 

Share Recommend | Keep | Reply | Mark as Last Read

From: Catfish5/8/2012 11:35:51 PM
   of 111110
 
OT: Petition to TD Ameritrade for continuing QuoteTracker support started on I-Hub. Every signature will help.

investorshub.advfn.com 

QuoteTracker being "phased out" at TDAmeritrade, sign Petition

I just spoke at length to two TD Ameritrade reps. They are indeed phasing out QuoteTracker, but said the draw down date isn't finalized. Both admitted that part of the problem is that "many" traders still use QuoteTracker.

I've been using QuoteTracker for over 10 years and the ThinkorSwim platform for about 2 years. I use them daily, side by side. In my opinion, many things about QuoteTracker are still superior to ThinkorSwim, and I really don't want to see QT phased out.

I've started a petition to see if we can influence TDA to keep QuoteTracker up and running:
www.thepetitionsite.com/565/267/854/dont-phase-out-quotetracker

Share Recommend | Keep | Reply | Mark as Last Read

From: Catfish5/9/2012 7:36:21 AM
3 Recommendations   of 111110
 
IMSC - .895 Interesting hire for the company.

Implant Sciences Appoints Dr. Darryl Jones as VP of Sales and Marketing Former Senior Executive at Company Competitors Safran (Morpho Detection) and GE Security







WILMINGTON, MA, May 09, 2012 (MARKETWIRE via COMTEX) -- Continuing its record of attracting top industry talent, Implant Sciences Corporation (otcqb:IMSC) (pinksheets:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced the appointment of Dr. Darryl Jones as Vice President of Sales and Marketing. Dr. Jones has led significant sales growth at some of the largest firms in the security industry including GE Security and Safran's Morpho Detection.

Dr. Jones stated, "Implant Sciences represents the next generation in explosives and narcotics trace detection. I see tremendous potential for further global and domestic market penetration for the Company's current products and its underlying technologies hold great promise for a larger product portfolio that can be rolled out to its global distribution network. I am excited to contribute to, and lead the Company's sales momentum."

Dr. Jones was most recently Vice President of Global Product Management at Safran's Morpho Detection, where he managed one of the largest ETD and EDS product portfolios in the industry, and helped launch the X-ray and Raman spectroscopy product lines. Prior to GE Security's sale to Safran, Dr. Jones was General Manager of Global Security Sales at GE Security, where he recruited and developed a global sales team focused on six key markets and achieved year-over-year top line growth. During his three year tenure as sales leader, Dr. Jones nearly tripled the revenue in the non-aviation markets. Previously, he was Global Business Manager at GE Healthcare, and a Senior Product Manager at Corning, Inc./Photonic Technologies. Dr. Jones has been issued a patent, authored six papers in scientific publications, and delivered nine conference presentations. He received his PhD in Optical Science and Engineering from the University of Alabama, a Masters of Arts in Physics and Bachelor of Arts from Fisk University.

"Darryl is a recognized industry leader who uniquely combines his deep technical knowledge with his innate skills in sales, marketing, management, and product portfolio development," stated Implant Sciences' President and CEO Glenn D. Bolduc. "The fact that he is joining us at this time points to the excitement around Implant Sciences' products, technologies, and our position of growth in the security industry. We are very pleased to welcome him to our growing team of management talent."

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive and narcotics trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and the Company's QS-B220 benchtop explosives and narcotics trace detector has received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com .

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the Transportation Security Administration or by other U.S. or foreign government and law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; the risks that our markets are subject to technological change and that our success depends on our ability to develop and introduce new products; that our success depends on our ability to obtain new patents and operate without infringing on the proprietary rights of others; that we may not obtain the patents we have applied for; that the validity and breadth of claims in technology patents involve complex legal and factual questions and, therefore, may be highly uncertain; that any patents we may obtain may be may be challenged and subsequently invalidated, that we may incur substantial costs in asserting our patent rights; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (2)

To: Catfish who wrote (107804)5/9/2012 9:45:22 AM
From: benignFeO21 Recommendation   of 111110
 
IMSC .90 - Bolduc nipped one from the competition ;)

Share Recommend | Keep | Reply | Mark as Last Read

To: Catfish who wrote (107804)5/9/2012 11:11:45 AM
From: D. K. G.1 Recommendation   of 111110
 
IMSC displaying nice relative strength in market down turn...

Last [Tick]Change% ChangeBid [Tick]Bid SizeAskAsk SizeOpenVolume
$0.949[-]
$0.054
6.03%
0.90
8000
$0.95
14800
$0.895
67,030

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

From: ACAN5/9/2012 11:41:57 AM
   of 111110
 
ATTUF BO and new 52 wk high, at 1.35 now on 167K

Share Recommend | Keep | Reply | Mark as Last Read

From: 1Coffeehound5/9/2012 1:26:17 PM
   of 111110
 
FLXT - Up .02 to .11 on fluff pr. Amazing! eom

Share Recommend | Keep | Reply | Mark as Last Read

From: Suma5/9/2012 4:30:55 PM
   of 111110
 
Arna which used to be posted here has been steadily rising. Anyone following it ?

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: Suma who wrote (107809)5/9/2012 4:43:53 PM
From: ktcougar   of 111110
 

Running into FDA advisory mtg tomorrow.


Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is awaiting its opportunity to readdress the U.S. Federal Food and Drug Administration's Advisory Committee, as it continues to seek approval for its weight-loss drug Locaserin. The meeting is scheduled for May 10, 2012.




kt

Share Recommend | Keep | Reply | Mark as Last Read
Previous 10 | Next 10 

Copyright © 1995-2013 Knight Sac Media. All rights reserved.